4) The main conclusion in terms of safety and the OHSS occurrence, drawn from retrospective studies and clinical trials, is that GnRH-a triggering almost completely eliminates early OHSS during and after stimulation in donation programs. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.